ArticleCancer medicine2023

Maintenance regimen of GM-CSF with rituximab and lenalidomide improves survival in high-risk B-cell lymphoma by modulating natural killer cells.

Shunrong Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.